FASN and cancer: Oestradiol is reported to upregulate FASN expression and drive proliferation in an FASN-dependent manner in several gynaecological cancers, including breast [123,124] and endometrial [125] cancer, by far making FASN the most studied FA metabolism enzyme, with regards to its alteration by oestradiol in gynaecological cancers.